Elevance Health (ELV) Cash & Equivalents (2009 - 2026)

Elevance Health (ELV) has 18 years of Cash & Equivalents data on file, last reported at $10.2 billion in Q2 2026.

• On a quarterly basis, Cash & Equivalents rose 19.53% year-over-year to $10.2 billion in Q2 2026; TTM through Jun 2026 was $10.2 billion, a 19.53% increase from a year earlier, with the FY2025 full-year figure at $9.5 billion, up 14.51% from the prior year.
• Cash & Equivalents for Q2 2026 stood at $10.2 billion, up from $9.7 billion in the prior quarter.
• Over the last five years, Cash & Equivalents for ELV reached as high as $10.9 billion in Q3 2023 and fell as low as $6.2 billion in Q1 2022.
• Historically, Cash & Equivalents has averaged $8.3 billion across 5 years, with a median of $8.4 billion in 2024.
• Across the five-year window, Cash & Equivalents jumped 64.62% in 2023 and slumped 38.61% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $7.4 billion in 2022, then fell by 11.66% to $6.5 billion in 2023, then advanced by 27.0% to $8.3 billion in 2024, then rose by 14.51% to $9.5 billion in 2025, then rose by 7.81% to $10.2 billion in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $10.2 billion in Q2 2026, $9.7 billion in Q1 2026, and $9.5 billion in Q4 2025.